Scarica l'app Stockscreener
9.79
2.62%
0.25
Dopo l'orario di chiusura:
9.79
Precedente Chiudi:
$9.54
Aprire:
$9.54
Volume 24 ore:
1.71M
Relative Volume:
2.10
Capitalizzazione di mercato:
$671.93M
Reddito:
-
Utile/perdita netta:
$-96.66M
Rapporto P/E:
-4.5535
EPS:
-2.15
Flusso di cassa netto:
$-83.73M
1 W Prestazione:
+11.38%
1M Prestazione:
+79.30%
6M Prestazione:
+160.37%
1 anno Prestazione:
-18.01%
Intervallo 1D:
$9.445
$9.92
Intervallo di 1 settimana:
$8.01
$9.92
Portata 52W:
$2.86
$13.51
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
Nome
Olema Pharmaceuticals Inc
Settore
Industria
Telefono
(415) 651-3316
Indirizzo
780 BRANNAN STREET, SAN FRANCISCO
Confronta OLMA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
9.79 | 654.77M | 0 | -96.66M | -83.73M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-12 | Reiterato | Citigroup | Buy |
| 2024-04-02 | Iniziato | Goldman | Buy |
| 2024-01-30 | Iniziato | Citigroup | Buy |
| 2023-07-21 | Iniziato | Oppenheimer | Outperform |
| 2023-05-05 | Iniziato | CapitalOne | Overweight |
| 2023-02-22 | Iniziato | Credit Suisse | Outperform |
| 2022-07-06 | Ripresa | Canaccord Genuity | Buy |
| 2022-06-09 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | Iniziato | H.C. Wainwright | Neutral |
| 2021-12-07 | Ripresa | Cowen | Outperform |
| 2020-12-14 | Iniziato | Canaccord Genuity | Buy |
| 2020-12-14 | Iniziato | Cowen | Outperform |
| 2020-12-14 | Iniziato | JP Morgan | Overweight |
| 2020-12-14 | Iniziato | Jefferies | Buy |
Mostra tutto
Olema Pharmaceuticals Inc Borsa (OLMA) Ultime notizie
Why Olema Pharmaceuticals Inc. stock attracts global investorsMarket Activity Report & Fast Moving Stock Watchlists - newser.com
Goldman Sachs Raises Stake in Olema Pharmaceuticals, Inc. (OLMA) - Insider Monkey
Will Olema Pharmaceuticals Inc. stock deliver better than expected guidancePortfolio Update Report & Risk Adjusted Swing Trade Ideas - newser.com
How analysts rate Olema Pharmaceuticals Inc. stock todayBull Run & Reliable Volume Spike Trade Alerts - newser.com
How to forecast Olema Pharmaceuticals Inc. trends using time series2025 Price Action Summary & Weekly Setup with High ROI Potential - newser.com
Will Olema Pharmaceuticals Inc. benefit from macro trends2025 Volatility Report & Fast Entry and Exit Trade Plans - newser.com
11 Best Fast Money Stocks to Buy Now - Insider Monkey
Chart based exit strategy for Olema Pharmaceuticals Inc.2025 Top Decliners & Free High Return Stock Watch Alerts - newser.com
What analysts say about Olema Pharmaceuticals Inc stockVolume Weighted Average Price & Low Risk Portfolio Growth - earlytimes.in
What drives Olema Pharmaceuticals Inc stock priceVolume Spike Alerts & Accelerated Financial Growth - earlytimes.in
Olema Pharmaceuticals (NASDAQ:OLMA) Trading 6.5% HigherHere's Why - MarketBeat
Olema Pharmaceuticals, Inc. $OLMA Stake Raised by Goldman Sachs Group Inc. - MarketBeat
Oppenheimer Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $22 - 富途牛牛
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Up 10.2%Time to Buy? - MarketBeat
Applying chart zones and confluence areas to Olema Pharmaceuticals Inc.Quarterly Portfolio Review & Fast Gaining Stock Reports - newser.com
Cyrus Harmon Sells 10,000 Shares of Olema Pharmaceuticals (NASDAQ:OLMA) Stock - MarketBeat
Olema Pharmaceuticals (NASDAQ:OLMA) Director Cyrus Harmon Sells 10,000 Shares - MarketBeat
Analyst Calls: Is Olema Pharmaceuticals Inc forming bullish engulfing patterns2025 Analyst Calls & Community Consensus Trade Alerts - خودرو بانک
This Insider Has Just Sold Shares In Olema Pharmaceuticals - simplywall.st
What’s the recovery path for long term holders of Olema Pharmaceuticals Inc.Weekly Trade Recap & Scalable Portfolio Growth Methods - newser.com
Aug Ideas: Should I invest in Olema Pharmaceuticals Inc before earningsDay Trade & Free Growth Oriented Trading Recommendations - خودرو بانک
Key resistance and support levels for Olema Pharmaceuticals Inc.Weekly Profit Analysis & Expert Curated Trade Setup Alerts - newser.com
Sentiment analysis tools applied to Olema Pharmaceuticals Inc.Quarterly Trade Summary & Trade Opportunity Analysis Reports - newser.com
Olema Pharmaceuticals Inc. stock prediction for this weekBreakout Watch & Technical Entry and Exit Tips - newser.com
Visual analytics tools that track Olema Pharmaceuticals Inc. performanceWeekly Trade Recap & AI Based Buy/Sell Signal Reports - newser.com
Highs Report: Does Olema Pharmaceuticals Inc outperform in volatile markets2025 Breakouts & Breakdowns & Weekly Top Performers Watchlists - خودرو بانک
What candlestick patterns are forming on Olema Pharmaceuticals Inc.2025 Winners & Losers & High Win Rate Trade Tips - newser.com
Buy Signal: Is Olema Pharmaceuticals Inc stock a top performer YTDJuly 2025 PostEarnings & Capital Protection Trading Alerts - خودرو بانک
Olema Pharmaceuticals Inc Azioni (OLMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.36%
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):